Keywords
antitubercular agents
schiff base
TEMA
How to Cite
Abstract
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis (MTB). Pyrazinamide (PZA) is a prodrug used in first-lines treatment. New drugs proposals are urgent, given the increased resistance to antimicrobials such as PZA. In this work, we have synthesized and characterized N'-[(1E)-(4-nitrophenyl)methylidene]pyrazine-2-carbohydrazide (C3), to evaluate its antituberculosis activity in vitro in MTB H37Rv (wild type) and DM97 (PZA resistant). C3 was synthesized and characterized by FT-IR and 1H / 13C NMR, among others. C3 is a hydrazone derived from PZA. Both compounds have an analogous and stable docking with the pyrazinamidase enzyme, according to our in-silico studies. In the tetrazolium microplate assay (TEMA) performed on MTB H37Rv at pH 6.0 and 6.8, it was found that PZA has greater antituberculosis activity than C3 on H37Rv, however, in DM97, C3 (MIC = 128 µg / mL at pH 6.0) presented greater antituberculosis activity than PZA (MIC > 800 µg / mL at pH 6.0), which demonstrates the antituberculosis potential of C3 against this strain resistant to PZA.
References
Abdel-Aziz, M.; Abdel-Rahman, H. M. Synthesis and anti-mycobacterial evaluation of some pyrazine-2-carboxylic acid hydrazide derivatives. Eur. J. Med. Chem. 2010, 45 (8), 3384–3388. https://doi.org/10.1016/j.ejmech.2010.04.025
Allouche, A. R. Gabedit—A graphical user interface for computational chemistry software. J. Comput. Chem. 2011, 32 (1),174–182. https://doi.org/10.1002/jcc.21600
Alvarado-Huayhuaz, J. A.; Talaverano-Rojas, D. A.; Huamán Quispe, R. I.; Dorneles Caldeira Balboni, M.; Arrúa Arce, O. E.; Velasque Werhli, A.; Santos Machado, K.; Valderrama-Negrón, A. C. Search for Zinc Complexes with High Affinity in Pyrazinamidase from Mycobacterium Tuberculosis Resistant to Pyrazinamide. In: Scherer, N. M.; Melo-Minardi, R. C. Eds.; Advances in Bioinformatics and Computational Biology; BSB 2022. Lecture Notes in Computer Science. Springer; 2022, 13523. https://doi.org/10.1007/978-3-031-21175-1_12
Benov, L. Effect of growth media on the MTT colorimetric assay in bacteria. PLoS One. 2019, 14 (8), e0219713. https://doi.org/10.1371/journal.pone.0219713
Bhaskar, R. S.; Ladole, C. A.; Salunkhe, N. G.; Barabde, J. M.; Aswar, A. S. Synthesis, characterization and antimicrobial studies of novel ONO donor hydrazone Schiff base complexes with some divalent metal (II) ions. Arab. J. Chem. 2019, 13 (8), 6559–6567. https://doi.org/10.1016/j.arabjc.2020.06.012
Bowers, K. J.; Chow, D. E.; Xu, H.; Dror, R. O.; Eastwood, M. P.; Gregersen, B. A.; Klepeis, J. L.; Kolossvary, I.; Moraes, M. A.; Sacerdoti, F. D. Scalable algorithms for molecular dynamics simulations on commodity clusters. In SC'06: Proceedings of the 2006 ACM/IEEE Conference on Supercomputing. 2006, pp. 43–43. IEEE. https://doi.org/10.1145/1188455.1188544
Carrasco, F.; Hernández, W.; Chupayo, O.; Sheen, P.; Zimic, M.; Coronel, J.; Álvarez, C. M.; Ferrero, S. Oramas-Royo, S.; Spodine, E. Phenylisoxazole-3/5-Carbaldehyde Isonicotinylhydrazone derivatives: Synthesis, Characterization, and Antitubercular Activity. J. Chem. 2021, 2021 (1), 1–14. https://doi.org/10.1155/2021/6014093
Chávez, N.; Ramírez, R.; Sheen, P.; Zimic, M.; Valderrama, A. Síntesis, caracterización y evaluación de la actividad biológica de compuestos de coordinación de cobalto con pirazinamida. Rev. Soc. Quím. Perú. 2020, 86 (3), 315–328. https://doi.org/10.37761/rsqp.v86i3.303
Daina, A.; Michielin, O.; Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 2017, 7 (1), 42717. https://doi.org/10.1038/srep42717
Dogan, H.; Dogan, Ş. D.; Gunduz, M. G.; Krishna, V. S.; Sarıpınar, E. Discovery of hydrazone containing thiadiazoles as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors. Eur. J. Med. Chem. 2020, 188, 112035. https://doi.org/10.1016/j.ejmech.2020.112035
Ferreira, M.; Candea, A. L.; O Henriques, G. M.; Kaiser, C. R.; Lima, C. H. S.; Souza, M. V. Synthesis and cytotoxic evaluation of disubstituted N-acylhydrazones pyrazinecarbohydrazide derivatives. Lett. Drug Des. Discov. 2010, 7 (4), 275–280. https://doi.org/10.2174/157018010790945814
Hanwell, M. D.; Curtis, D. E.; Lonie, D. C.; Vandermeersch, T.; Zurek, E.; Hutchison, G. R. Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J. Cheminform. 2012, 4 (1), 17. https://doi.org/10.1186/1758-2946-4-17
Hegde, G. S.; Netalkar, S. P.; Revankar, V. K. Copper (II) complexes of 3,5‐di‐tert‐butyl‐2‐hydroxybenzoylhydrazones of 2‐formylpyridine and 2‐acetylpyridine, with tautomeric azine‐scaffold‐based architecture: Synthesis, crystal structures, the effect of counteranions on complexation, and their anti‐microbial and anti‐tuberculosis evaluation. Appl. Organomet. Chem. 2019, 33 (7), e4840. https://doi.org/10.1002/aoc.4840
Instituto de Investigaciones de la Amazonía Peruana (IIAP). Centro de Alto Rendimiento Computacional de la Amazonia Peruana. Systèmes D., “BIOVIA.” San Diego, 2020.
Jorgensen, W. L.; Chandrasekhar, J.; Madura, J. D.; Impey, R. W.; Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 1983, 79 (2), 926–935. https://doi.org/10.1063/1.445869
Junaid, M.; Khan, M. T.; Malik, S. I.; Wei, D. Q. Insights into the mechanisms of the pyrazinamide resistance of three pyrazinamidase mutants N11K, P69T, and D126N. J. Chem. Inf. Model. 2019, 59 (1), 498–508. https://doi.org/10.1021/acs.jcim.8b00525
Kardan-Yamchi J.; Kazemian, H.; Battaglia, S.; Abtahi, H.; Rahimi, F. A.; Hamzelou, G.; Cirillo, D. M.; Ghodousi, A.; Feizabadi, M. M. Whole Genome Sequencing Results Associated with Minimum Inhibitory Concentrations of 14 Anti-Tuberculosis Drugs among Rifampicin-Resistant Isolates of Mycobacterium Tuberculosis from Iran. J. Clin. Med. 2020, 9 (2), 465. https://doi.org/10.3390/jcm9020465
Lee, C.; Yang, W.; Parr, R. G. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys. Rev. B. 1988, 37 (2), 785. https://doi.org/10.1103/PhysRevB.37.785
Liu, Y.; Peterson, D. A.; Kimura, H; Schubert, D. Mechanism of cellular 3‐(4, 5‐dimethylthiazol‐2‐yl)‐2, 5‐diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 1987, 69 (2), 581–593. https://doi.org/10.1046/j.1471-4159.1997.69020581.x
Ministry of Health of Peru (MINSA), Perfil de la tuberculosis en el Perú. 2019. [Online]. Available: https://www.dge.gob.pe/portal/docs/tools/teleconferencia/2022/SE272022/03.pdf. (accessed 2023-01-19).
Neese, F. Software update: the ORCA program system, version 4.0. Wiley Interdiscip. Rev. Comput. Mol. Sci. 2018, 8 (1), e1327. https://doi.org/10.1002/wcms.1327
Peterson, N. D.; Rosen, B. C.; Dillon, N. A.; Baughn, A. D. Uncoupling Environmental pH and Intrabacterial Acidification from Pyrazinamide Susceptibility in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2015, 59 (12), 7320–7326. https://doi.org/10.1128/AAC.00967-15
Petrella, S.; Gelus-Ziental, N.; Maudry, A.; Laurans, C.; Boudjelloul, R.; Sougakoff, W. Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis: Insights into Natural and Acquired Resistance to Pyrazinamide. PLoS ONE. 2011, 6 (1). e15785. https://doi.org/10.1371/journal.pone.0015785
Piddington, D. L; Kashkouli, A.; Buchmeier, N. A. Growth of Mycobacterium tuberculosis in a Defined Medium Is Very Restricted by Acid pH and Mg2+ Levels. Infect. Immunity. 2000, 68 (8), 4518–4522. https://doi.org/10.1128/IAI.68.8.4518-4522.2000
Schrödinger Release, 2022-2: Induced Fit Docking protocol; Glide, Schrödinger, LLC, New York, NY, 2021; Prime, Schrödinger, LLC, New York, NY, 2021. Available: https://www.schrodinger.com/products/glide (accessed 2022-06-12).
Shebl, M. Coordination behavior of new bis(tridentate ONO, ONS and ONN) donor hydrazones towards some transition metal ions: Synthesis, spectral, thermal, antimicrobial and antitumor studies. J. Mol. Struct. 2017, 1128, 79–93. https://doi.org/10.1016/j.molstruc.2016.08.056
Shebl, M.; Saleh, A. A.; Khalil, S. M.; Dawy, M.; Ali, A. A. Synthesis, spectral, magnetic, DFT calculations, antimicrobial studies and phenoxazinone synthase biomimetic catalytic activity of new binary and ternary Cu(II), Ni(II) and Co(II) complexes of a tridentate ONO hydrazone ligand. Inorg. Nano-Met. Chem. 2020, 51 (2), 195–209. https://doi.org/10.1080/24701556.2020.1770794
Sheen, P.; Lozano, K.; Gilman, H.; Valencia, J.; Loli, S.; Fuentes, P.; Zimic, M. pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis. Tuberculosis. 2013, 93 (5), 515–522. https://doi.org/10.1016/j.tube.2013.03.005
Silva, Y. K. C.; Augusto, C. V.; Castro, M. L.; Albuquerque, G. M.; de Queiroz, A. C.; Dias, D. F.; Alexandre-Moreira, M. S. Synthesis and pharmacological evaluation of pyrazine N-acylhydrazone derivatives designed as novel analgesic and anti-inflammatory drug candidates. Bioorg. Med. Chem. 2010, 18 (14), 5007–5015. https://doi.org/10.1016/j.bmc.2010.06.002
Singh, P.; Mishra, A. K.; Malonia, S. K.; Chauhan, D. S.; Sharma, V. D.; Venkatesan, K.; Katoch, V. M. The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria. J. Commun. Dis. 2006, 38 (3), 288.
Srivastava, G.; Darokar, M. P; Sharma, A. Molecular investigation against the resistant mechanism of PncA mutated pyrazinamide resistance and insight into the role of pH environment for pyrazinamide activation. J. Biomol. Struct. Dyn. 2019, 38 (11), 3411–3431. https://doi.org/10.1080/07391102.2019.1659854
Sun, Q.; Li, X.; Perez, M.; Shi, W.; Zhang, Y.; Sacchettini, C. The molecular basis of pyrazinamide activity on Mycobacterium tuberculosis PanD. Nat. Commun. 2020, 11 (1), 339. https://doi.org/10.1038/s41467-019-14238-3
Supo-Escalante, R. R.; Médico, A.; Gushiken, E.; Olivos-Ramírez, G. E.; Quispe, Y.; Torres, F.; Zimic, M. Prediction of Mycobacterium tuberculosis pyrazinamidase function based on structural stability, physicochemical and geometrical descriptors. Plos One. 2020, 15 (7), e0235643. https://doi.org/10.1371/journal.pone.0235643
Tariq, S.; Khalid, M.; Raza, A. R.; Rubab, S. L.; Alcântara Morais, S. F.; Khan, M. U.; Braga, A. C. Experimental and computational investigations of new indole derivatives: A combined spectroscopic, SC-XRD, DFT/TD-DFT and QTAIM analysis. J. Mol. Struct. 2020, 1207, 127803. https://doi.org/10.1016/j.molstruc.2020.127803
Valderrama Negrón, A. C.; Ramirez Panti, R. I.; Aliaga Paucar, C. M.; Grandez Arias, F.; Sheen Cortovaria, P.; Zimic Peralta, M. J.; Cauna Orocollo, Y. Pyrazinamide-isoniazid hybrid: synthesis optimisation, characterisation, and antituberculous activity. Rev. Colomb. Quim. 2021, 50 (3), 16–23. https://doi.org/10.15446/rev.colomb.quim.v50n3.96424
Vergara, F. M.; Lima, C. D.; Maria, M. D.; Candéa, A. L.; Lourenço, M. C.; Ferreira, M. D.; Souza, M. V. Synthesis and antimycobacterial activity of N′-[(E)-(monosubstituted-benzylidene)]-2-pyrazinecarbohydrazide derivatives. Eur. J. Med. Chem. 2009, 44 (12), 4954–4959. https://doi.org/10.1016/j.ejmech.2009.08.009
Wang, Z. N'-(2-Hydroxy-3-methoxybenzylidene)pyrazine-2- carbohydrazide monohydrate. IUCrDATA. 2020, 5 (1), x191731. https://doi.org/10.1107/S2414314619017310
World Health Organization (WHO). Global tuberculosis report. 2023. [Online]. Available: https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2023 (accessed 2023-01-08).
Zhang, Y.; Shi, W.; Zhang, W.; Mitchison, D. Mechanisms of pyrazinamide action and resistance. Microbiol Spectr. 2014, 2 (4), 2–4. https://doi.org/10.1128/microbiolspec.MGM2-0023-2013
Zhang, Y.; Wade, M.; Scorpio, A.; Zhang, H.; Sun, Z. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J. Antimicrob. Chemother. 2003, 52 (5), 790–795. https://doi.org/10.1093/jac/dkg446
Zülfikaroğlu, A.; Yüksektepe, Ç.; Çelikoğlu, E.; Çelikoğlu, U.; İdil, Ö. New Cu(II), Co(III) and Ni(II) metal complexes based on ONO donor tridentate hydrazone: Synthesis, structural characterization, and investigation of some biological properties. J. Mol. Struct. 2020, 1199, 127012. https://doi.org/10.1016/j.molstruc.2019.127012
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Eclética Química